Intestinal epithelial dysplasia

Tufting enteropathy

Congenital enteropathy

Congenital familial intractable diarrhea with enterocytes assembly abnormalities

Intestinal epithelial dysplasia (IED), also known as tufting enteropathy, is a congenital enteropathy presenting with early-onset severe intractable diarrhea and persistent villous atrophy with low or without mononuclear cell infiltration of the lamina propria but specific histological abnormalities involving the epithelium 12. IED is characterized by clinical and histological heterogeneity and association with malformations or other epithelial diseases. It is thought to be related to abnormal enterocytes development and/or differentiation.

IED appears to be more common than microvillous atrophy (MVA), also known as microvillous inclusion disease (MVID), especially in Middle-East, however, it remains very rare. Many cases are not yet recognized since the description of this disorder is recent. To date, no epidemiological data are available, however, the prevalence can be estimated at around 1/50,000–100,000 live births in Western Europe. The largest cohort of patients is currently being treated at the Necker-Enfants Malades Hospital in Paris, France. The prevalence is higher in countries with high degree of consanguinity. Our studies indicate that IED is frequent in patients of Arabic origin (Middle-East, Turkey and North Africa). The prevalence is also high in the island of Malta (in the Mediterranean sea) but the phenotype appears to be milder.

IDE is a newly described clinicopathologic entity with intractable diarrhea in infants. Three cases of neonatal severe diarrhea with abnormal epithelial pictures were first reported by Reifen et al., 1994, under the name of 'tufting enteropathy" 3. We identified nine cases of severe neonatal diarrhea, which were clearly distinguishable from MVA and resembled "tufting enteropathy" 4. Further studies of these patients allowed us to identify IED as a constitutive epithelial disorder involving both small intestine and colon 5. A main characteristic of this disease is its clinical and histological heterogeneity and its association with malformations or other epithelial diseases.

In general, infants with IDE develop watery diarrhea within the first days after birth. It is severe in most of the cases. Stool volumes may be as high as 100–200 ml/kg body weight per day, with electrolyte concentrations similar to those seen in small intestinal fluid. In rare cases the diarrhea may be less abundant and sometimes may mislead the diagnosis 5. The growth is impaired. There is no past history of hydramnios suggesting congenital chloride diarrhea or sodium malabsorption diarrhea. Most patients have consanguineous parents and/or affected siblings, some of whom died during the first months of life from severe diarrhea of unknown origin.

Several cases of IED have been reported as being associated with phenotypic abnormalities, for example Dubowitz syndrome or malformative syndrome 678. Some affected children are reported to have dysmorphic facial features 6. An association between congenital intractable diarrhea of infancy (IDI) and choanal atresia has been reported in four children 7. We have observed malformations, including esophageal atresia, choanal atresia, or unperforated anus. Moreover, nonspecific punctuated keratitis is observed in more than 60% of patients 8. This associated keratitis is very intriguing since it is also an epithelial disease and therefore studies of keratitis might help to elucidate the molecular mechanisms of the intestinal epithelial disease. The fact that some children have ophthalmological symptoms and keratitis highlights the heterogeneity of IED (Salomon et al., manuscript in preparation).

Histological abnormalities in IED include villous atrophy, disorganization of the surface epithelium and basement membrane abnormalities.

Neonatal early-onset severe diarrhea may lead to suspect ions transport defects. However, congenital chloride diarrhea (CLD) or congenital sodium diarrhea (CSD) can be easily distinguished from the absence of hydramnios and by blood and stool electrolytes assessment 91011. CLD is a rare autosomal recessive disorder of intestinal Cl/HCO3 exchange caused by mutations in the SLC26A3 gene and characterized by persistent Cl rich diarrhea from birth 910. Patients with CLD present with lifetime watery diarrhea with a high Cl content and low pH, causing dehydration and hypochloremic metabolic alkalosis. Chloride is low in urine and very high in stools (Chloride > 150 mmol/L > Sodium).

CSD is caused by defective sodium/proton exchange with only few sporadic cases reported 11. The genetics of the disease have not yet been established. Patients with CSD have acidosis and hyponatremia, and stools with high concentrations of HCO3 and sodium (150 mmol/L).

Glucose-galactose malabsorption (GGM) is an autosomal recessive disease that presents in newborn infants as a life-threatening diarrhea 12. The diarrhea ceases within 1 h of removing the oral intake of lactose, glucose, and galactose, but promptly returns with the introduction of one or more of the offending sugars into the diet.

IED should be suspected in neonates with early-onset intractable diarrhea persisting at bowel rest. According to the early onset of diarrhea, MVA can be suspected. MVA is a congenital disorder of the intestinal epithelial cells that presents with persistent life-threatening watery diarrhea and is characterized by morphological enterocyte abnormalities 13. MVID manifests either in the first days of life (early-onset form) or in the first two months of life (late-onset form). MVID is a very rare disorder of unknown origin, probably transmitted as an autosomal recessive trait. Light microscopy shows accumulation of PAS-positive granules at the apical pole of immature enterocytes, together with atrophic band indicating microvillus atrophy and, in parallel, an intracellular PAS or CD10 positive line. Ultrastructural analyses reveal a partial to total atrophy of microvilli on mature enterocytes with apical accumulation of numerous secretory granules in immature enterocytes.

Sometimes, histopathological presentation of IED does not show evidence of tufts. Diagnosis can be made by performing repeated intestinal biopsies. Indeed, biopsies change from being near-normal in early life (showing only signs of non specific villous atrophy, with or without monocellular cell infiltration of the lamina propria) to revealing the characteristic tufts. In addition, specific abnormalities of basement membrane components (integrins or desmosomes) in parts of mucosa are rare and difficult to detect in the absence of tufts 5. In patients with neonatal diarrhea and villous atrophy in which MVA has been ruled out, the evidence of a punctuated keratitis is very relevant for the diagnosis of IED, since more than 60% of IED have this association. IED differs from the disease reported in a newborn presenting with pyloric atresia, intractable diarrhea and severe dermatitis which was thought to be related to a congenital deficiency of α6β4 integrin 15.

Another difficulty is related to T-cell infiltration of the lamina propria. This is especially problematic when the tufts are missing and supports the hypothesis of an immune-related enteropathy. In a mouse model of dysfunctional E-cadherin, this primary disorder of epithelial permeability or integrity was responsible for secondary T-cell mediated mucosal damage 16. Murch et al. described these types of lesions in infants with epithelial dysplasia 17. Despite the lack of evidence from clinical studies, increased intestinal permeability with subsequent antigen epithelial crossing might explain immune reaction within the lamina propria. Finally, this inflammation reaction with missing or hard-to-find tufts often leads to treat the disease as an immune enteropathy. In our experience, several children have been referred with the diagnosis of autoimmune enteropathy unresponsive to immunosuppressive treatment and severe iatrogenic symptoms from long-term steroids treatment.

IED has been shown to be associated with an abnormal basement membrane 3. Basement membrane molecules are involved in epithelial mesenchymal cell interactions, which are instrumental in intestinal development and differentiation 181920212223. Alterations suggestive of abnormal cell-cell and cell-matrix interactions have been seen in patients with IED without any evidence for abnormalities in epithelial cell polarization and proliferation 4. Alterations included abnormal distribution of α2β1 integrin adhesion molecules along the crypt-villous axis. The α2β1 integrin is involved in the interaction of epithelial cells with various basement membrane components, such as laminin and collagen. To date, the pathophysiological mechanisms resulting in the increased immunohistochemical expression of desmoglein and the ultrastructural changes of the desmosomes are unclear 4. Mice in which the gene encoding the transcription factor Elf3 is disrupted have morphologic features resembling epithelial dysplasia in infants 24. In this model, there is abnormal morphogenesis of the villi, while progenitor crypt cells appear normal. The enterocytes produce low levels of transforming growth factor-beta type 2 receptor, which induces the differentiation of immature intestinal epithelia. Both the clinical studies and the findings in experimental animal models should provide clues to the pathogenesis of these epithelial abnormalities and to the cause of the severity of this neonatal diarrhea. Tufts correspond to nonapoptotic epithelial cells at the villous tips that are no longer in contact with the basement membrane. It can be speculated that a defect in normal enterocyte apoptosis at the end of their lifespan or altered cell-cell interactions are responsible for this effect. The primary or secondary nature of the formation of tufts remains to be determined.

The clear association between the occurrence of IDE and the presence of parental consanguinity and/or affected siblings strongly suggests a genetic origin of this disorder. These features suggest an autosomal recessive transmission. Genetic counseling may be based on the very probable autosomal recessive mode of transmission. Since the causative gene(s) have not been yet identified, prenatal diagnosis is not possible.

IDE may be life-threatening, since the massive diarrhea leads to rapid dehydration and electrolyte imbalance, with subsequent metabolic decompensation within a few days after birth. Diarrhea persists at a lower level despite bowel rest. Attempts at continuous enteral feeding (CEF) with a protein hydrolysate or amino acids based formulas worsen the diarrhea, and the newborns rapidly fail to thrive and develop protein energy malnutrition. Unfortunately, patients have been continued on long-term enteral feeding (EF) without improvement of the diarrhea and with progressive severe protein energy malnutrition. As mentioned above, the same is true for patients treated with immunosuppressive drugs (especially steroids) some time associated with cyclosporine because of mucosal inflammation. Finally, most of the time this neonatal diarrhea, which resists all treatments, requires permanent parenteral nutrition (PN). However, it seems that some infants have a milder phenotype than others 25. Infants with partial intestinal function and a limited amount of stool output require only partial long-term PN infusions 3–4 times per week. Nevertheless, careful monitoring should be performed to avoid progressive growth retardation.

In most patients, the severity of the intestinal malabsorption and diarrhea make them totally dependent on daily long-term PN, with a subsequent risk of complications. IDE causes intestinal failure that is clearly irreversible in most patients. Liver disease may develop with subsequent end-stage liver cirrhosis in patients with intestinal failure as a consequence of both underlying digestive disease and unadapted PN. Management of patients with intestinal failure requires an early recognition of the condition and analysis of the risk of irreversibility. Thus, in some cases IED is an indication for intestinal transplantation 26272829 and timing of referral for intestinal transplantation is crucial.

The criteria for transplantation have been published in the position paper of the American Society of Transplantation 30 and continue to be debated, especially regarding vascular thrombosis and sepsis. They are more guidelines than formal recommendations and must be balanced with the risks of intestinal transplantation. For instance, in our practice only repeated life-threatening sepsis, especially when complicated with extensive thrombosis, may be a criterion for transplantation. The poor quality of life might serve as indication for intestinal transplantation (ITx), although usual criteria including progressive liver disease, the loss of vascular access, and recurring life-threatening sepsis have not developed. In any case, parents must be extensively informed about the risks of the procedure and about the reasons of any decision 31.

Patients with irreversible intestinal failure and end-stage liver disease (liver cirrhosis) are candidates for a life-saving procedure such as combined liver-small bowel transplantation (LITx). Patients with severe hepatic fibrosis are more difficult to manage 31. Repeated liver biopsies within 6 to 12 months and careful assessment for portal hypertension are necessary. In addition, it is difficult to assess the amount of functional liver tissue necessary to withstand the insult of portal diversion during the transplantation procedure. Children with severe advanced and progressive hepatic fibrosis are usually listed for LITx. However, some PN-dependent patients with advanced liver dysfunction may experience functional and biochemical liver recovery.

In any case, when long-term PN is effective and well tolerated, it can be used for a prolonged period of time without intestinal transplantation. The long-term prognosis is variable. In general, management should be based on a multidisciplinary approach in centers involving pediatric gastroenterology, parenteral nutrition expertise, home parenteral nutrition program, and liver intestinal transplantation program.